Wird geladen...

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrome, increases worldwide representing now the prevalent liver disease in western countries. No pharmacotherapy is approved for the treatment of N...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Endocrinol (Lausanne)
Hauptverfasser: Seghieri, Marta, Christensen, Alexander S., Andersen, Andreas, Solini, Anna, Knop, Filip K., Vilsbøll, Tina
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2018
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6232120/
https://ncbi.nlm.nih.gov/pubmed/30459715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00649
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!